Aug 31 (Reuters) – Abbisko Cayman Limited: * THERAPEUTICS COMPLETES FIRST PATIENT DOSING IN PHASE I TRIAL OF ABSK211 Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Shares skid in Asia as oil climbs, yields stay high
By Wayne Cole SYDNEY, Aug 31 (Reuters) - Share markets slid on Monday in Asia…
NEPAL FLOOD: AT LEAST 933 HYDROPOWER PROJECT WORKERS BELIEVED TRAPPED IN TUNNELS - NATIONAL DISASTER…
G20 countries should consider more trade barriers on China to cut imbalances, Bessent says
By David Lawder ASHEVILLE, North Carolina, Aug 30 (Reuters) - U.S. Treasury Secretary Scott Bessent…
